Heart disease in myasthenia gravis

Area of Science:

• Neurology
• Cardiology
• Pathology

Background:

• Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
• Cardiac complications in MG patients are not fully understood.
• Previous studies suggest a potential link between MG and heart disease.

Purpose of the Study:

• To determine the frequency and type of heart disease in myasthenia gravis patients.
• To investigate the relationship between MG and cardiac manifestations.
• To compare cardiac disease prevalence in MG patients with a control group.

Main Methods:

• Retrospective analysis of medical data from 108 myasthenia gravis patients.
• Assessment of cardiac disease signs, including arrhythmias.
• Histopathological examination of cardiac tissue from thymoma patients.
• Comparison with 44 spinal muscular atrophy patients as controls.

Main Results:

• 16% of MG patients (17 of 108) exhibited signs of heart disease.
• Cardiac symptoms, primarily arrhythmias, were observed in 10% of MG patients (11 of 108).
• Focal myocarditis was identified in all examined hearts of MG patients with thymoma; 5 patients experienced sudden death.

Conclusions:

• Heart disease, particularly focal myocarditis and arrhythmias, is significantly associated with myasthenia gravis.
• The cardiac pathology in MG patients shows microscopic similarities to skeletal muscle lesions.
• These findings indicate a specific MG-related etiology for the observed heart disease.